Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Vanguard Medica and SmithKline Beecham terminate frovatriptan collaboration

May 20, 1998

New treatments for Alzheimer's disease in the pipeline at Schering-Plough

May 20, 1998

Neuroprotective heterocyclic compounds developed at Cambridge NeuroScience

May 19, 1998

Rivastigmine ameliorates immediate and long-term sequelae of closed-head injury

May 19, 1998

Postmarketing evaluation of Clozaril may lead to increased patient availability

May 19, 1998

Scios and Janssen to copromote Risperdal

May 18, 1998

European Commission approves Novartis' Exelon

May 18, 1998

Ondansetron suppresses spontaneous sleep apnea in rats

May 18, 1998

Novel isoquinolines prepared at Snow Brand Milk Products inhibit neuronal cell death

May 15, 1998

TheraTech and Astra announce collaborative development of new pain medication

May 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...